Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
Osteoporos Int
; 29(1): 41-47, 2018 01.
Article
in En
| MEDLINE
| ID: mdl-28975362
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteoporosis, Postmenopausal
/
Withholding Treatment
/
Bone Density Conservation Agents
/
Denosumab
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
Language:
En
Journal:
Osteoporos Int
Journal subject:
METABOLISMO
/
ORTOPEDIA
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: